Medication use is associated with fatigue in a sample of community-living individuals who have a spinal cord injury: A chart review

Spinal Cord

Volumn 48, Issue 5, 2010, Pages 429-433

  Lee, A K Y ^a   Miller, W C ^a,b,c,d   Townson, A F ^a,b,c,d   Anton, H A ^a,b,c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b International Collaboration on Repair Discoveries   (Canada)

^c VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^d GF STRONG REHABILITATION CENTRE   (Canada)

Author keywords

Fatigue; Medications; Outpatients; Rehabilitation

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUNARIZINE; GASTROINTESTINAL AGENT; NEUROLEPTIC AGENT; SPASMOLYTIC AGENT; TRIMEBUTINE;

ADULT; AGED; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PAIN; PRIORITY JOURNAL; REHABILITATION CENTER; SPINAL CORD INJURY;

ADOLESCENT; ADULT; ANALGESICS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CAUSALITY; COMMUNITY MEDICINE; COMORBIDITY; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; IATROGENIC DISEASE; INDEPENDENT LIVING; MALE; MIDDLE AGED; PARASYMPATHOLYTICS; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SPINAL CORD INJURIES; YOUNG ADULT;

EID: 77952241402     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2009.145     Document Type: Article

References (14)

1. Herlofson K, Larsen JP. Measuring fatigue in patients with Parkinson's diseaseFthe fatigue severity scale. Eur J Neurol 2002; 9: 595-600.
2. Gerhart KA, Weitzenkamp DA, Kennedy P, Glass CA, Charlifue SW. Correlates of stress in long-term spinal cord injury. Spinal Cord 1999; 37: 183-190.
3. McColl M, Arnold R, Charlifue S, Glass C, Savic G, Frankel H. Aging, spinal cord injury, and quality of life: structural relationships. Arch Phys Med Rehabil 2003; 84: 1137-1144.
4. McColl M, Charlifue S, Glass C, Lawson N, Savic G. Aging, gender and spinal cord injury. Arch Phys Med Rehabil 2004; 85: 363-367.
5. Fawkes-Kirby TM, Wheeler MA, Anton HA, Miller WC, Townson AF,Weeks CAO. Clinical correlates of fatigue in spinal cord injury. Spinal Cord 2008; 46: 21-25.
6. Oken BS, Flegal K, Zajdel D, Kishiyama SS, Lovera J, Bagert B et al. Cognition and fatigue in multiple sclerosis: potential effects of medications with central nervous system activity. J Rehabil Res Dev 2006; 43: 83-90.
7. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: applications to patients with multiple sclerosis and systematic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123.
8. Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004; 56: 157-170.
9. Egner A, Phillips VL, Vora R, Wiggers E. Depression, fatigue, and health-related quality of life among people with advanced multiple sclerosis: results from an exploratory telerehabilitation study. NeuroRehabilitation 2003; 18: 125-133.
10. Anton HA, Miller WC, Townson AF. Measuring fatigue in persons with spinal cord injury. Arch Phys Med Rehabil 2008; 89: 538-542.
11. Canadian Pharmacists Association. Compendium of Pharmaceuticals and Specialties 2008: The Canadian Drug Reference for Health Care Professionals. Canadian Pharmacists Association: Ottawa, 2008.
12. Chadhauri A, Behan PO. Fatigue in neurological disorders. Lancet 2004; 363: 978-988.
13. Murray RF, Asghari A, Egorov DD, Rutkowski SB, Siddall PJ, Soden RJ et al. Impact of spinal cord injury on self-perceived pre- and postmorbid cognitive, emotional, and physical functioning. Spinal Cord 2007; 45: 429-436.
14. Barat M, Dehail P, de Seze M. Fatigue after spinal cord injury. Ann Readapt Med Phys 2003; 49: 365-369.